Goldman Myla Lai - Net Worth and Insider Trading
Goldman Myla Lai Net Worth
The estimated net worth of Goldman Myla Lai is at least $5 Million dollars as of 2024-11-08. Goldman Myla Lai is the EVP & Chief Medical Officer of Labcorp Holdings Inc and owns about 22,660 shares of Labcorp Holdings Inc (LH) stock worth over $5 Million. Goldman Myla Lai is the Director of Akoya Biosciences Inc and owns about 20,000 shares of Akoya Biosciences Inc (AKYA) stock worth over $64,760. Goldman Myla Lai is also the Director of Sequenom Inc and owns about 4,000 shares of Sequenom Inc (SQNM) stock worth over $9,560. Details can be seen in Goldman Myla Lai's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Goldman Myla Lai has not made any transactions after 2023-06-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Goldman Myla Lai
Goldman Myla Lai Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Goldman Myla Lai owns 4 companies in total, including West Pharmaceutical Services Inc (WST) , Sequenom Inc (SQNM) , and Labcorp Holdings Inc (LH) among others .
Click here to see the complete history of Goldman Myla Lai’s form 4 insider trades.
Insider Ownership Summary of Goldman Myla Lai
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| WST | West Pharmaceutical Services Inc | 2014-02-18 | director |
| SQNM | Sequenom Inc | 2016-09-07 | director |
| LH | Labcorp Holdings Inc | 2008-03-26 | EVP & Chief Scientific Officer |
 | | 2023-06-12 | director |
Goldman Myla Lai Latest Holdings Summary
Goldman Myla Lai currently owns a total of 3 stocks. Among these stocks, Goldman Myla Lai owns 22,660 shares of Labcorp Holdings Inc (LH) as of March 26, 2008, with a value of $5 Million and a weighting of 98.65%. Goldman Myla Lai owns 20,000 shares of Akoya Biosciences Inc (AKYA) as of June 12, 2023, with a value of $64,760 and a weighting of 1.18%. Goldman Myla Lai also owns 4,000 shares of Sequenom Inc (SQNM) as of November 29, 2012, with a value of $9,560 and a weighting of 0.17%.
Latest Holdings of Goldman Myla Lai
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LH | Labcorp Holdings Inc | 2008-03-26 | 22,660 | 239.05 | 5,416,873 |
| AKYA | Akoya Biosciences Inc | 2023-06-12 | 20,000 | 3.24 | 64,760 |
| SQNM | Sequenom Inc | 2012-11-29 | 4,000 | 2.39 | 9,560 |
Holding Weightings of Goldman Myla Lai
Goldman Myla Lai Form 4 Trading Tracker
According to the SEC Form 4 filings, Goldman Myla Lai has made a total of 0 transactions in Labcorp Holdings Inc (LH) over the past 5 years. The most-recent trade in Labcorp Holdings Inc is the sale of 3,400 shares on March 26, 2008, which brought Goldman Myla Lai around $247,588.
According to the SEC Form 4 filings, Goldman Myla Lai has made a total of 1 transactions in Akoya Biosciences Inc (AKYA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Akoya Biosciences Inc is the acquisition of 20,000 shares on June 12, 2023, which cost Goldman Myla Lai around $100,000.
According to the SEC Form 4 filings, Goldman Myla Lai has made a total of 0 transactions in Sequenom Inc (SQNM) over the past 5 years. The most-recent trade in Sequenom Inc is the acquisition of 4,000 shares on November 29, 2012, which cost Goldman Myla Lai around $18,360.
Insider Trading History of Goldman Myla Lai
- 1
Goldman Myla Lai Trading Performance
GuruFocus tracks the stock performance after each of Goldman Myla Lai's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Goldman Myla Lai is -10.57%. GuruFocus also compares Goldman Myla Lai's trading performance to market benchmark return within the same time period. The performance of stocks bought by Goldman Myla Lai within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Goldman Myla Lai's insider trading performs compared to the benchmark.
Performance of Goldman Myla Lai
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.4 | | | | | |
| Relative Return to S&P 500(%) | 15.34 | | | | | |
Goldman Myla Lai Ownership Network
Ownership Network List of Goldman Myla Lai
Ownership Network Relation of Goldman Myla Lai
Goldman Myla Lai Owned Company Details
What does West Pharmaceutical Services Inc do?
Who are the key executives at West Pharmaceutical Services Inc?
Goldman Myla Lai is the director of West Pharmaceutical Services Inc. Other key executives at West Pharmaceutical Services Inc include VP & Treasurer Charles Witherspoon , Chief Executive Officer Eric Mark Green , and Chief Digital & Trans Officer Silji Abraham .
West Pharmaceutical Services Inc (WST) Insider Trades Summary
Over the past 18 months, Goldman Myla Lai made no insider transaction in West Pharmaceutical Services Inc (WST). Other recent insider transactions involving West Pharmaceutical Services Inc (WST) include a net sale of 314,864 shares made by Eric Mark Green , a net sale of 7,621 shares made by Charles Witherspoon , and a net sale of 16,972 shares made by Silji Abraham .
In summary, during the past 3 months, insiders sold 1,732 shares of West Pharmaceutical Services Inc (WST) in total and bought 0 shares, with a net sale of 1,732 shares. During the past 18 months, 391,827 shares of West Pharmaceutical Services Inc (WST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 391,827 shares.
West Pharmaceutical Services Inc (WST)'s detailed insider trading history can be found in Insider Trading Tracker table.
West Pharmaceutical Services Inc Insider Transactions
Goldman Myla Lai Mailing Address
Above is the net worth, insider trading, and ownership report for Goldman Myla Lai. You might contact Goldman Myla Lai via mailing address: 3595 John Hopkins Court, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
